rectal cancer

John Strickler, MD, and team's milestone work on the clinical trial "MOUNTAINEER" has led to the first FDA-approved treatment regimen for HER2+ metastatic colorectal cancer.

DCI radiation oncologist Christine Eyler, MD, PhD, was awarded an NCI Mentored Clinical Scientist Research Career Development Award for rectal cancer and chemo-radiotherapy research.

For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.